
### [NCIT:C8155](http://purl.obolibrary.org/obo/NCIT_C8155)
**Label:** Recurrent Grade 1 Follicular Lymphoma

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.87%
- [NCIT:C28077](http://purl.obolibrary.org/obo/NCIT_C28077) (Grade 1) 51.35%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36177](http://purl.obolibrary.org/obo/NCIT_C36177) (Single-File Linear Pattern))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36176](http://purl.obolibrary.org/obo/NCIT_C36176) (Bilateral Mass))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36163](http://purl.obolibrary.org/obo/NCIT_C36163) (Metastatic/Recurrent Disease))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36158](http://purl.obolibrary.org/obo/NCIT_C36158) (Chronic Clinical Course))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36157](http://purl.obolibrary.org/obo/NCIT_C36157) (Acute Clinical Course))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36155](http://purl.obolibrary.org/obo/NCIT_C36155) (Accelerated Phase of Disease))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36154](http://purl.obolibrary.org/obo/NCIT_C36154) (Chronic Phase of Disease))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36141](http://purl.obolibrary.org/obo/NCIT_C36141) (Intermediate Grade Lesion))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36140](http://purl.obolibrary.org/obo/NCIT_C36140) (Grade 4 Lesion))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36134](http://purl.obolibrary.org/obo/NCIT_C36134) (Undifferentiated Lesion))) 36.71%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36133](http://purl.obolibrary.org/obo/NCIT_C36133) (Well Differentiated Lesion))) 36.71%


